Entos Pharmaceuticals
PrivateLast Round
Grant
Aug 1, 2025
Total Funding Raised
$126.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Entos Pharmaceuticals is a biotechnology company developing genetic medicines using its proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Entos Pharmaceuticals Comparables
Compare Entos Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoVation Therapeutics | 89% | |
| Acuitas Therapeutics | 87% | |
| Genevant Sciences | 87% | |
Entos Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2025 | ||||
| VC Round | May 22, 2025 | ||||
| Grant | Mar 11, 2025 | ||||
| Grant | Feb 5, 2025 | ||||
| Grant | Oct 7, 2023 | ||||
Grant | Oct 1, 2022 |
Entos Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Canadian International Innovation Program | Grant |
| CureDuchenne Ventures | VC Round |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| National Research Council Canada | Grant |
| Government of Canada | Grant |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Developing a curative therapy for LMNA-Related Congenital Muscular Dystrophy.
- Apr 20, 2026
Partnered with L-CMD Research Foundation to develop curative therapy.
Entos Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Entos Pharmaceuticals's valuation, stock price, and market status.